Medtronic (MDT)
NYSE: MDT
· Real-Time Price · USD
92.89
0.04 (0.04%)
At close: Sep 05, 2025, 3:59 PM
92.36
-0.57%
After-hours: Sep 05, 2025, 06:45 PM EDT
Medtronic Revenue Breakdown
| Period Ending | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | Apr 24, 2020 | Jan 24, 2020 | Oct 25, 2019 | Jul 26, 2019 | Apr 26, 2019 | Jan 25, 2019 | Oct 26, 2018 | Jul 27, 2018 | Apr 27, 2018 | Jan 26, 2018 | Oct 27, 2017 | Jul 28, 2017 | Apr 28, 2017 | Jan 27, 2017 | Oct 28, 2016 | Jul 29, 2016 | Apr 29, 2016 | Jan 29, 2016 | Oct 30, 2015 | Jul 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiac and Vascular Group Revenue | 3.33B | 3.04B | 3.1B | 3.01B | 3.13B | 2.15B | 963M | 578M | 3.31B | 570M | 556M | 541M | 2.96B | 2.75B | 2.83B | 2.89B | 2.71B | 2.73B | 2.43B | 2B | 2.82B | 2.85B | 2.79B | 3.05B | 2.79B | 2.86B | 2.81B | 3.13B | 2.8B | 2.77B | 2.65B | 2.85B | 2.55B | 2.58B | 2.52B | 2.74B | 2.41B | 2.48B | 2.57B |
| Cardiac and Vascular Group Revenue Growth | +9.81% | -2.10% | +3.16% | -3.90% | +45.67% | +123.05% | +66.61% | -82.56% | +481.58% | +2.52% | +2.77% | -81.73% | +7.87% | -2.90% | -2.18% | +6.76% | -0.66% | +12.00% | +21.41% | -28.91% | -1.26% | +2.33% | -8.52% | +9.48% | -2.52% | +1.67% | -10.33% | +11.96% | +0.97% | +4.80% | -7.09% | +11.77% | -1.39% | +2.62% | -8.00% | +13.57% | -2.90% | -3.31% | n/a |
| Diabetes Group Revenue | 728M | 694M | 686M | 647M | 307M | 2.93B | 2.14B | 2.04B | 595M | 2.14B | 2.07B | 2B | 597M | 584M | 585M | 572M | 630M | 574M | 562M | 570M | 610M | 596M | 592M | 626M | 610M | 583M | 572M | 645M | 584M | 462M | 449M | 512M | 501M | 462M | 452M | 495M | 474M | 450M | 445M |
| Diabetes Group Revenue Growth | +4.90% | +1.17% | +6.03% | +110.75% | -89.52% | +36.74% | +5.05% | +242.69% | -72.16% | +3.24% | +3.45% | +235.18% | +2.23% | -0.17% | +2.27% | -9.21% | +9.76% | +2.14% | -1.40% | -6.56% | +2.35% | +0.68% | -5.43% | +2.62% | +4.63% | +1.92% | -11.32% | +10.45% | +26.41% | +2.90% | -12.30% | +2.20% | +8.44% | +2.21% | -8.69% | +4.43% | +5.33% | +1.12% | n/a |
| Medical Surgical Revenue | 2.21B | 2.07B | 2.13B | 2B | 2.09B | 640M | 2.29B | 2.22B | 2.23B | 2.25B | 2.19B | 2.12B | 2.23B | 2.29B | 2.3B | 2.32B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Medical Surgical Revenue Growth | +6.71% | -2.63% | +6.61% | -4.41% | +226.25% | -72.03% | +3.11% | -0.27% | -1.02% | +2.84% | +3.36% | -5.16% | -2.62% | -0.39% | -0.99% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Neuroscience Group Revenue | 2.62B | 2.46B | 2.45B | 2.32B | 2.54B | 2.35B | n/a | n/a | 2.41B | n/a | n/a | n/a | 2.3B | 2.14B | 2.14B | 2.2B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Neuroscience Group Revenue Growth | +6.59% | +0.29% | +5.78% | -8.92% | +8.03% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +7.28% | +0.37% | -3.09% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | Apr 24, 2020 | Jan 24, 2020 | Oct 25, 2019 | Jul 26, 2019 | Apr 26, 2019 | Jan 25, 2019 | Oct 26, 2018 | Jul 27, 2018 | Apr 27, 2018 | Jan 26, 2018 | Oct 27, 2017 | Jul 28, 2017 | Apr 28, 2017 | Jan 27, 2017 | Oct 28, 2016 | Jul 29, 2016 | Apr 29, 2016 | Jan 29, 2016 | Oct 30, 2015 | Jul 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ireland Revenue | 29M | 28M | 29M | 4.08B | 4.34B | 4.12B | 4.17B | 3.92B | 4.48B | 4.06B | 4.07B | 3.77B | 4.1B | 3.94B | 4B | 4.1B | 4.18B | 3.94B | 4.05B | 3.35B | 2.85B | 4.02B | 4.13B | 3.92B | 4.28B | 4B | 4.04B | 22M | 23M | 3.91B | 22M | 4.04B | 13.15B | 8.52B | 8.67B | 4.3B | 4.51B | 4.23B | 4.39B | 4.45B |
| Ireland Revenue Growth | +3.57% | -3.45% | -99.29% | -6.01% | +5.41% | -1.32% | +6.40% | -12.33% | +10.19% | -0.17% | +8.05% | -8.06% | +3.99% | -1.48% | -2.51% | -1.91% | +6.14% | -2.84% | +20.98% | +17.50% | -29.07% | -2.62% | +5.39% | -8.54% | +7.07% | -1.09% | +18286.36% | -4.35% | -99.41% | +17681.82% | -99.46% | -69.27% | +54.44% | -1.78% | +101.79% | -4.81% | +6.74% | -3.67% | -1.24% | n/a |
| Total Other Countries, Excluding United States And Ireland Revenue | 4.35B | 4.03B | 4.07B | 30M | 28M | 27M | 29M | 29M | 27M | 23M | 25M | 23M | 24M | 24M | 27M | 26M | 27M | 25M | 24M | 24M | 20M | 22M | 23M | 20M | 23M | 24M | 22M | 3.5B | 3.93B | 20M | 3.29B | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Other Countries, Excluding United States And Ireland Revenue Growth | +8.02% | -1.06% | +13466.67% | +7.14% | +3.70% | -6.90% | 0.00% | +7.41% | +17.39% | -8.00% | +8.70% | -4.17% | 0.00% | -11.11% | +3.85% | -3.70% | +8.00% | +4.17% | 0.00% | +20.00% | -9.09% | -4.35% | +15.00% | -13.04% | -4.17% | +9.09% | -99.37% | -11.08% | +19570.00% | -99.39% | +16370.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 4.55B | 4.24B | 4.3B | 3.8B | 4.22B | 3.94B | 3.78B | 3.75B | 4.04B | 3.64B | 3.49B | 3.58B | 3.97B | 3.8B | 3.82B | 3.86B | 3.98B | 3.81B | 3.57B | 3.13B | 3.13B | 3.67B | 3.55B | 3.56B | 3.84B | 3.52B | 3.41B | 3.86B | 4.19B | 3.44B | 3.73B | 3.33B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +7.34% | -1.56% | +13.17% | -9.84% | +7.00% | +4.29% | +0.83% | -7.23% | +10.96% | +4.33% | -2.54% | -9.71% | +4.39% | -0.60% | -0.96% | -2.99% | +4.41% | +6.78% | +13.95% | +0.19% | -14.92% | +3.38% | -0.03% | -7.40% | +9.03% | +3.13% | -11.65% | -7.71% | +21.82% | -7.95% | +12.20% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jul 25, 2025 | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | Apr 24, 2020 | Jan 24, 2020 | Oct 25, 2019 | Jul 26, 2019 | Apr 26, 2019 | Jan 25, 2019 | Oct 26, 2018 | Jul 27, 2018 | Apr 27, 2018 | Jan 26, 2018 | Oct 27, 2017 | Jul 28, 2017 | Apr 28, 2017 | Jan 27, 2017 | Oct 28, 2016 | Jul 29, 2016 | Apr 29, 2016 | Jan 29, 2016 | Oct 30, 2015 | Jul 31, 2015 | Apr 24, 2015 | Jan 23, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.81B | 2.72B | 2.72B | 2.76B | 2.65B | 2.77B | 2.67B | 2.69B | 2.61B | 2.62B | 2.62B | 2.62B | 2.57B | 2.57B | 2.56B | 2.62B | 2.55B | 2.6B | 2.54B | 2.6B | 2.42B | 2.36B | 2.59B | 2.62B | 2.54B | 2.62B | 2.6B | 2.6B | 2.6B | 2.55B | 2.52B | 2.54B | 2.58B | 2.48B | 2.39B | 2.42B | 2.43B | 2.36B | 2.32B | 2.34B | 2.45B | 2.4B | 1.49B |
| Selling, General, and Administrative Revenue Growth | +3.16% | +0.11% | -1.45% | +3.84% | -3.98% | +3.44% | -0.48% | +2.79% | -0.11% | +0.04% | -0.08% | +1.95% | -0.08% | +0.31% | -2.07% | +2.67% | -1.85% | +2.29% | -2.42% | +7.57% | +2.46% | -8.81% | -1.26% | +3.03% | -2.94% | +0.92% | -0.35% | +0.31% | +1.76% | +1.15% | -0.63% | -1.59% | +4.07% | +3.81% | -1.16% | -0.49% | +2.88% | +1.86% | -1.11% | -4.33% | +1.87% | +61.67% | n/a |
| Research and Development Revenue | 726M | 684M | 675M | 697M | 676M | 675M | 695M | 698M | 668M | 639M | 688M | 676M | 692M | 652M | 657M | 676M | 750M | 632M | 601M | 639M | 621M | 567M | 573M | 603M | 587M | 594M | 561M | 590M | 585M | 592M | 559M | 556M | 548M | 553M | 530M | 554M | 556M | 575M | 546M | 545M | 558M | 528M | 373M |
| Research and Development Revenue Growth | +6.14% | +1.33% | -3.16% | +3.11% | +0.15% | -2.88% | -0.43% | +4.49% | +4.54% | -7.12% | +1.78% | -2.31% | +6.13% | -0.76% | -2.81% | -9.87% | +18.67% | +5.16% | -5.95% | +2.90% | +9.52% | -1.05% | -4.98% | +2.73% | -1.18% | +5.88% | -4.92% | +0.85% | -1.18% | +5.90% | +0.54% | +1.46% | -0.90% | +4.34% | -4.33% | -0.36% | -3.30% | +5.31% | +0.18% | -2.33% | +5.68% | +41.55% | n/a |